Keywords: Contrast Agents, Contrast Agents, MRI; MRSI; pH; Temperature; Biosensors; Transition metals
Motivation: Lanthanide ion-based first-generation MRI contrast agents (like GBCAs) enhance detection of pathologic structures by shortening water proton relaxation but provide no physiological information.
Goal(s): Develop second-generation MRI agents that enhance relaxivity-based detection and selectively map physiological parameters through hyperfine shifted proton resonances.
Approach: Designing and synthesizing novel paramagnetic MR agents with Co(II) and Ni(II) ions coordinated phosphonated macrocyclic ligands for pH biosensing, aiding early detection of tumors, ensuring clinical translation.
Results: We synthesized Co(II) and Ni(II) coordinated phosphonated macrocyclic complexes [M(II)L]. Co(II)Lx- has 6.5 ppm/pH sensitivity, 1.5-fold larger than TmDOTP5-, while Ni(II)Lx- has 2.7 ppm/pH, comparable to TmDOTP5-.
Impact: The Co(II)Lx- exhibited highest pH sensitivity among all reported biosensors. These biocompatible pH sensors are under evaluation for in vivo pH mapping, aiming to enable early cancer diagnosis and holding strong potential for clinical translation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords